The effect of atropine and duct decompression on the evolution of Diazinon-induced acute canine pancreatitis.
Three groups of eight dogs each were studied to evaluate the early evolution of the hyperamylasemia, hyperlipasemia, and acinar cell pathology at the light and electron microscopic levels during acute Diazinon-induced pancreatitis. Two more groups of five dogs each were evaluated for the effects of cholinergic receptor blockade with atropine and ductal decompression on the evolution of serum enzyme changes and acinar cell pathology. Group I dogs received a secretin infusion of 2 units/kg/hr, and a Diazinon infusion of 75 mg/kg, and demonstrated significant increases in serum amylase and lipase at one, two and three hours. Light microscopy revealed acinar cell vacuolization and progressive interstitial edema. Electron microscopy revealed the formation of large intracytoplasmic vacuoles filled with flocculent material, the fusion of these vacuoles with basolateral membrane, and the formation of interstitial edema. In both group II dogs (that received secretin alone) and Group III dogs (that received atropine, 200 micrograms/kg IV prior to secretin and Diazinon), the serum enzyme levels and histologic results were normal. In group IV dogs, pancreatic duct cannulation to prevent hypertension prevented the hyperamylasemia and hyperlipasemia, but not the acinar cell vacuolization and interstitial edema. This model for acute interstitial pancreatitis is apparently cholinergic-receptor mediated, the serum enzyme elevations are due primarily to ductal hypertension, and the acinar cell pathology is primarily due to cholinergic stimulation and occurs independent of ductal hypertension.
D000208:Acute Disease; D000681:Amylases / Q000097:blood; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D002802:Cholinesterases / Q000378:metabolism; D003976:Diazinon; D004195:Disease Models, Animal; D004285:Dogs; D007306:Insecticides; D007440:Intubation; D008049:Lipase / Q000097:blood; D008854:Microscopy, Electron; D010179:Pancreas / Q000473:pathology; D010183:Pancreatic Ducts; D010195:Pancreatitis / Q000139:chemically induced* / Q000201:enzymology / Q000473:pathology; D012633:Secretin / Q000494:pharmacology
D007306:Insecticides; D012633:Secretin; D001285:Atropine; D008049:Lipase; D002802:Cholinesterases; D000681:Amylases; D003976:Diazinon